Pharmigene, Inc. (TPEX:7595)
Taiwan · Delayed Price · Currency is TWD 7.33
0.00 (0.00%)
Sep 8, 2026, 1:25 PM CST
Pharmigene Market Cap
Pharmigene has a market cap or net worth of 369.91 million as of September 8, 2026. Its market cap has decreased by -33.96% in one year.
Market Cap
369.91M
Enterprise Value
918.77M
Revenue
187.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.33
ChartMarket Cap Chart
Since December 22, 2020, Pharmigene's market cap has decreased from 1.08B to 369.91M, a decrease of -65.82%. That is a compound annual growth rate of -17.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 369.91M | -25.96% |
| Dec 31, 2025 | 499.60M | -30.53% |
| Dec 31, 2024 | 719.13M | -31.16% |
| Dec 29, 2023 | 1.04B | 21.08% |
| Dec 30, 2022 | 862.78M | -8.53% |
| Dec 30, 2021 | 943.19M | -13.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 2.95B |
| DIVA Laboratories | 1.91B |
| Puriblood Medical | 1.07B |
| Genetics Generation Advancement | 1.05B |
| Kim Forest Enterprise | 745.74M |
| Sofiva Genomics | 736.33M |
| TFBS Bioscience | 663.84M |
| Welgene Biotech | 379.86M |